- Home
- AARD vs RTB Comparison
AARD vs RTB Comparison
Compare AARD & RTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | RTB |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.7M | 128.6M |
| IPO Year | 2025 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AARD | RTB |
|---|---|---|
| Price | $4.46 | $8.00 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.11 | N/A |
| AVG Volume (30 Days) | 109.7K | ★ 124.3K |
| Earning Date | 11-12-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.11 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,131,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.35 | $6.83 |
| 52 Week High | $16.60 | $20.75 |
Technical Indicators
Market Signals| Indicator | AARD | RTB |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 37.30 |
| Support Level | $3.38 | $8.00 |
| Resistance Level | $5.88 | $11.40 |
| Average True Range (ATR) | 0.45 | 0.97 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 0.00 | 10.83 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About RTB RTB Digital Inc. Common Stock
RTB Digital Inc is focused on developing and operating a professional SaaS (Software as a Service) platform that hosts an exclusive coalition of professionally managed online media channels. Its operations include software development, advertising and sponsorship sales, and onboarding third-party content operators (Platform Partners) to publish content on the platform.